-UltraShape CONTOUR I to be Included in Four Presentations at the
Aesthetic Meeting 2007-
YOQNEUM, ISRAEL & SAN RAMON, CALIF., April 20 /CNW/ - The UltraShape
CONTOUR I, the first clinically proven non-invasive solution for body
contouring based on focused ultrasound technology, will be featured in the Hot
Topics panel "Emerging Technology in Plastic Surgery" at the Aesthetic Meeting
2007, the annual meeting for The American Society of Plastic Surgery (ASAPS)
and The Aesthetic Surgery Education and Research Foundation (ASERF). The
presentation, "Non-Invasive Lipolsysis by External Focused UltraSound
(UltraShape CONTOUR I)," will be presented by plastic surgeon Dr. Benjamin
"This year UltraShape's clinical findings are not only included in the
highly-watched Hot Topics panel, but also featured in three additional
scientific and clinical presentations, which demonstrates continued clinical
success and global market adoption of the technology," explained Rodger
Stewart, President and Chief Executive Officer of UltraShape Inc.
"Furthermore, Dr. Ascher's results are consistent with the commercial
experience that many physicians outside the United States have seen performing
the UltraShape(R) procedure in their practices."
Ascher was selected to present on his extensive experience using the
UltraShape CONTOUR I in his plastic surgery practice in Paris, France. His
data following three treatments at three week intervals demonstrated that 92%
of his patients experienced measurable circumference reduction. In addition,
88% of patients expressed satisfaction with their results. Ascher noted the
importance of appropriate patient selection and setting the right
"Through my own studies I have seen that most of the patients not only
respond well to the treatment, but also express great satisfaction due to the
convenience of the 'walk-in, walk-out' session and no requirements for
maintenance treatments," explained Ascher. "I have found that the UltraShape
CONTOUR I system is an effective non-invasive body contouring solution for the
abdomen, flanks and thighs and could possibly be considered an alternative to
conventional liposuction for the appropriate candidates."
Dr. Ascher is a leading plastic surgeon specializing in plastic,
aesthetic and reconstructive surgery and body contouring. He is a member of
the French Society of Plastic, Aesthetic and Reconstructive Surgery (SOFPRE).
He is the Scientific Director of IMCAS Congresses, International Master
Courses on Aging Skin and teacher leader in Europe for Plastic Surgeons and
Additional Presentations at ASAPS Highlighting UltraShape
In addition to the Hot Topics panel, UltraShape will be featured in the
-- Friday, April 20, 2007 - Advances in Minimally Invasive Face & Body
Rejuvenation Featuring Live Patient Demonstrations: "Non-Surgical Fat Removal"
By: Jeffrey M. Kenkel, M.D., Professor and Vice Chairman of the Department of
Plastic Surgery at the University of Texas Southwestern Medical Center at
Dallas and Chairman, UltraShape North America Medical Advisory Board.
-- Sunday, April 22, 2007 - Ancillary Light, Radiofrequency, Ultrasound,
and Wire-Release Procedures in Your Practice: "Introduction and Review of
Clinical Studies to Date of Non-Invasive Body Contouring using UltraShape" By:
Gordon Sasaki, M.D., Clinical Professor of Plastic Surgery at Loma Linda
University Medical School.
-- Tuesday, April 24, 2007 - Minimally Invasive Body Contouring Surgery:
"Non-Invasive Body Contouring With Focused Ultrasound Using UltraShape CONTOUR
I" By: Steven Teitelbaum, M.D., Assistant Clinical Professor of Plastic
Surgery at the David Geffen School of Medicine at UCLA, Medical Director of
the Santa Monica Institute of Laser and Esthetic Surgery, Member, UltraShape
North America Medical Advisory Board, and Principal Clinical Investigator in
UltraShape's completed and published multi-center worldwide controlled
"These presentations further conclude that the UltraShape CONTOUR I has
been scientifically demonstrated to produce definitive, measurable
circumference and fat thickness reduction without pain or downtime. It has
also been shown to selectively target and disrupt fat without harming
surrounding tissues," said Kenkel.
About the UltraShape CONTOUR I
The UltraShape CONTOUR I system, based on patented focused ultrasound
technology, is the first clinically proven non-invasive body contouring
solution for both men and women. It is designed to target and disrupt fat,
leaving surrounding structures such as skin, blood vessels, and nerves intact.
The UltraShape procedure is guided by proprietary real-time tracking and
guidance software designed to deliver smooth, uniform body contouring results.
The software guarantees adherence to a pre-determined treatment algorithm
minimizing risk of contour irregularities, a common side effect of liposuction
which is a highly technique-sensitive surgical procedure.
The UltraShape procedure is performed during a convenient, "walk-in,
walk-out" session carried out in an office-based environment; it requires no
anesthesia or sedation, and the vast majority of patients report no pain or
discomfort. After treatment, patients immediately resume their daily routines
and there is no need for maintenance treatments. The UltraShape CONTOUR I
system received the CE Mark in June 2005 and is currently distributed in 45
countries outside of the United States. Over 30,000 commercial treatments have
been performed worldwide with high patient satisfaction.
UltraShape Inc., founded in 2000, is a privately held and venture backed
company that develops, manufactures and markets innovative, non-invasive
solutions for the aesthetic medical field. The UltraShape expert team is
dedicated to the development of cutting-edge body-contouring technology in a
mission to enhance patients' self-image and sense of well-being. The
UltraShape CONTOUR I, the first clinically proven non-invasive body contouring
solution based on focused ultrasound technology, received the CE Mark in June
2005 and is currently distributed in 45 countries outside the United States.
Over 30,000 commercial treatments have been performed to-date.
The concept behind the company's platform technology was developed by Ami
Glicksman, M.D., a plastic surgeon and Yoram Eshel, Ph.D., MBA, a medical
physicist who teamed up to marry the aesthetic clinical experience of the
doctor and the expertise in high power focused ultrasound of the physicist.
UltraShape adheres to the highest scientific and quality standards and is
ISO 13485: 2003 certified. The company has worldwide offices in the United
States, Israel, France, United Kingdom, and Italy. The UltraShape CONTOUR I
system is not cleared by the FDA for marketing in the United States.
For more information, please visit www.ultrashape.com.
For further information:
For further information: FischerHealth Amanda McNulty Sheldon,
310-577-7870 x 173 email@example.com or UltraShape Abigail Marks,
+972-4-909-9260 Abigail@ultrashape.com or Porter Novelli Dariela Roffe,